BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11473959)

  • 1. Oral contraceptive use in relation to age at menopause in the DOM cohort.
    de Vries E; den Tonkelaar I; van Noord PA; van der Schouw YT; te Velde ER; Peeters PH
    Hum Reprod; 2001 Aug; 16(8):1657-62. PubMed ID: 11473959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age at natural menopause in a population-based screening cohort: the role of menarche, fecundity, and lifestyle factors.
    van Noord PA; Dubas JS; Dorland M; Boersma H; te Velde E
    Fertil Steril; 1997 Jul; 68(1):95-102. PubMed ID: 9207591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of relationship between hip and spine bone mineral density and oral contraceptive use.
    Murphy S; Khaw KT; Compston JE
    Eur J Clin Invest; 1993 Feb; 23(2):108-11. PubMed ID: 8462619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and breast cancer.
    Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
    Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer.
    Grabrick DM; Hartmann LC; Cerhan JR; Vierkant RA; Therneau TM; Vachon CM; Olson JE; Couch FJ; Anderson KE; Pankratz VS; Sellers TA
    JAMA; 2000 Oct; 284(14):1791-8. PubMed ID: 11025831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex hormones and cardiovascular risk.
    La Vecchia C
    Hum Reprod; 1992 Feb; 7(2):162-7. PubMed ID: 1577926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age of menarche is associated with knee joint replacement due to primary osteoarthritis (The HUNT Study and the Norwegian Arthroplasty Register).
    Hellevik AI; Nordsletten L; Johnsen MB; Fenstad AM; Furnes O; Storheim K; Zwart JA; Flugsrud G; Langhammer A
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1654-1662. PubMed ID: 28705605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary infertility and oral contraceptive steroid use.
    Bagwell MA; Thompson SJ; Addy CL; Coker AL; Baker ER
    Fertil Steril; 1995 Jun; 63(6):1161-6. PubMed ID: 7750582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal and reproductive influences and risk of melanoma in women.
    Smith MA; Fine JA; Barnhill RL; Berwick M
    Int J Epidemiol; 1998 Oct; 27(5):751-7. PubMed ID: 9839729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptives and breast cancer.
    Kalache A; McPherson K; Barltrop K; Vessey MP
    Br J Hosp Med; 1983 Oct; 30(4):278-83. PubMed ID: 6640197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive use and risk of colorectal cancer.
    Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
    Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of oral contraceptive use and risk of spontaneous abortion.
    Hahn KA; Hatch EE; Rothman KJ; Mikkelsen EM; Brogly SB; Sørensen HT; Riis AH; Wise LA
    Ann Epidemiol; 2015 Dec; 25(12):936-41.e1. PubMed ID: 26452607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and breast cancer: the current controversy.
    Pike MC; Chilvers C
    J R Soc Health; 1985 Feb; 105(1):5-10. PubMed ID: 3919185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.